RNF215
RING finger protein 215
Also known as: RN215_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6U7
- Gene
- RNF215
- Ensembl
- ENSG00000099999
- Chromosome
- 22
- Canonical length
- 377 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli,Microtubules
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in ubiquitin-dependent protein catabolic process. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>Q9Y6U7|RNF215
1 MGPAARPALR SPPPPPPPPP SPLLLLLPLL PLWLGLAGPG AAADGSEPAA GAGRGGARAV
61 RVDVRLPRQD ALVLEGVRIG SEADPAPLLG GRLLLMDIVD AEQEAPVEGW IAVAYVGKEQ
121 AAQFHQENKG SGPQAYPKAL VQQMRRALFL GASALLLLIL NHNVVRELDI SQLLLRPVIV
181 LHYSSNVTKL LDALLQRTQA TAEITSGESL SANIEWKLTL WTTCGLSKDG YGGWQDLVCL
241 GGSRAQEQKP LQQLWNAILL VAMLLCTGLV VQAQRQASRQ SQRELGGQVD LFKRRVVRRL
301 ASLKTRRCRL SRAAQGLPDP GAETCAVCLD YFCNKQWLRV LPCKHEFHRD CVDPWLMLQQ
361 TCPLCKFNVL GNRYSDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNF215 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 25 nTPM
- cerebral cortex: 19 nTPM
- cervix: 17 nTPM
- hypothalamus: 16 nTPM
- basal ganglia: 15 nTPM
- amygdala: 15 nTPM
Single-cell type
- epicardial cells: 66 nCPM
- proximal tubule cells: 52 nCPM
- müller glia: 48 nCPM
- myonuclei: 45 nCPM
- retinal ganglion cells: 35 nCPM
- early primary spermatocytes: 34 nCPM
Immune cell
- NK-cell: 2.5 nTPM
- naive B-cell: 1.9 nTPM
- naive CD4 T-cell: 1.8 nTPM
- naive CD8 T-cell: 1.7 nTPM
- eosinophil: 1.5 nTPM
- plasmacytoid DC: 1.4 nTPM
Brain region
- hypothalamus: 30 nTPM
- medulla oblongata: 30 nTPM
- cerebral cortex: 29 nTPM
- amygdala: 28 nTPM
- midbrain: 28 nTPM
- basal ganglia: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.5
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNF215 as an antibody target. Whether an autoantibody or antibody against RNF215 could matter depends on whether native RNF215 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNF215 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNF215 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...